Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: A randomized controlled trial

Annals of Thoracic Surgery

Volumn 81, Issue 3, 2006, Pages 886-891

  Pappalardo, Federico ^a   Valle, Patrizia Della ^b   Crescenzi, Giuseppe ^b   Corno, Chiara ^b   Franco, Annalisa ^b   Torracca, Lucia ^b   Alfieri, Ottavio ^b   Galli, Laura ^b   Zangrillo, Alberto ^b   D'Angelo, Armando ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHORYLCHOLINE; THROMBIN; TRANEXAMIC ACID;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; FIBRINOLYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STANDARDIZATION; SURFACE PROPERTY; THROMBOCYTE COUNT;

AGED; ANTIFIBRINOLYTIC AGENTS; BIOCOMPATIBLE MATERIALS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; EXTRACORPOREAL CIRCULATION; FEMALE; HEMOSTATICS; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; PLATELET COUNT; REOPERATION; TREATMENT OUTCOME;

EID: 32644482947     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.09.006     Document Type: Article

References (17)

1. J.M. Albes, I.M. Stohr, M. Kaluza Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating J Thorac Cardiovasc Surg 126 2003 1504 1512
2. F. De Somer, Y. Van Belleghem, F. Caes Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass J Thorac Cardiovasc Surg 123 2002 951 958
3. F. De Somer, K. Francois, W. van Oeveren Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface Eur J Cardiothorac Surg 18 2000 602 606
4. F. De Somer, Y. Van Belleghem, F. Caes Phosphorylcholine offers natural platelet preservation during cardiopulmonary bypass Perfusion 17 2002 39 44
5. M. Ranucci, A. Pazzaglia, G. Isgro Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass the intraoperative ECMO concept Int J Artif Organs 25 2002 875 881
6. E.J. Campbell, V. O'Byrne, P.W. Stanford Biocompatible surfaces using methacryloylphoshporilcoline laurylmethacrylate copolymer ASAIO J 40 1994 M853 M857
7. J.F. Hardy, J. Perrault, N. Tremblay, D. Robitaille, R. Blain, M. Carrier The stratification of cardiac surgical procedures according to use of blood products a retrospective analysis of 1480 cases Can J Anaesth 38 1991 511 517
8. V. Casati, C. Gerli, A. Franco Tranexamic acid in off-pump coronary surgery a preliminary, randomized, double-blind, placebo-controlled study Ann Thorac Surg 72 2001 470 475
9. G.D. Buckberg, F. Beyersdorf, B.S. Allen, J.M. Robertson Integrated myocardial management background and initial application J Card Surg 10 1995 68 89
10. M. Ranucci, A. Mazzucco, R. Pessotto Heparin-coated circuits for high-risk patients a multicenter, prospective, randomized trial Ann Thorac Surg 67 1999 994 1000
11. K.W. van der Kamp, W. van Oeveren Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery Int J Artif Organs 16 1993 836 842
12. E.J. Campbell, V. O'Byrne, P.W. Stratford Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer ASAIO J 40 1994 M853 M857
13. V. Casati, P. Della Valle, S. Benussi Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery comparison between on-pump and off-pump techniques J Thorac Cardiovasc Surg 128 2004 83 91
14. V. Henn, J.R. Slupsky, M. Grafe CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Nature 391 1998 591 594
15. V. Henn, S. Steinbach, K. Buchner, P. Presek, R.A. Kroczek The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40 Blood 98 2001 1047 1054
16. G. Soslau, J. Horrow, I. Brodsky Effect of tranexamic acid on platelet ADP during extracorporeal circulation Am J Hematol 38 1991 113 119
17. M. Ranucci, G. Isgro', G. Soro, A. Canziani, L. Menicanti, A. Frigiola Reduced systemic heparin dose with phosphorylcholine coated closed circuit in coronary operations Int J Artif Organs 27 2004 311 319